GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress

15.08.2022 - GreenLight raised $108.4 million in private placement led by S2G Ventures with strong participation from existing and new investors with cash expected to fund critical programs through the first half of 2023.GreenLight and Samsung Biologics ...

Related Keywords

India ,Japan ,United States ,Colorado ,China ,South Africa ,Wuhan ,Hubei ,South Korea ,Morningside ,Gauteng ,America ,South African ,Barney Graham ,Samsung Biologics ,David Pesci ,Insud Pharma ,Sigmas Group ,Continental Grain Company ,National Institute Of Allergy ,Melinda Gates Foundation ,Vaccine Program ,Nasdaq ,Samsung ,Serum Institute ,Serum Institute Of India ,Paribas Ecosystem Restoration Fund ,Us Environmental Protection Agency ,Vaccine Research Center ,Cummings Foundation ,National Institutes Of Health ,Greenlight Human Health Scientific Advisory Board ,World Health Organization ,African Health Products Regulatory Authority ,Recent Operational Highlights ,Protection Agency ,Powdery Mildew ,Diamondback Moth ,National Institutes ,Samsung Biologic Songdo ,Clinical Trials Application ,Investigational New Drug ,Latin America ,Middle East ,Melinda Gates ,Ecosystem Restoration Fund ,Cormorant Asset Management ,Fall Line Capital ,Morningside Venture Investments ,Rivas Capital ,Human Health Scientific Advisory ,Research Center ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Consolidated Statements ,Consolidated Balance Sheets ,Media Relations ,Light Biosciences ,